Arbutus Biopharma (ABUS) Acquisitions (2015)
Arbutus Biopharma recorded quarterly Acquisitions of $324000.0 in Q1 2015.
Arbutus Biopharma's Acquisitions history runs 1 years deep, the most recent figure standing at $324000.0 for Q1 2015.
- In Q1 2015, Acquisitions changed N/A year-over-year to $324000.0; the TTM figure through Dec 2015 stood at $324000.0 (changed N/A YoY), while the FY2015 annual figure was $324000.0, changed N/A from the prior year.
- Acquisitions came in at $324000.0 for Q1 2015 at Arbutus Biopharma.
- In the past five years, Acquisitions ranged from a high of $324000.0 in Q1 2015 to a low of $324000.0 in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Arbutus Biopharma | 883.58 Mn | 883.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 324,000.00 |